Home>Topics>Stocks>Becton

Becton BDX

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. Headlines
    1. Diversify Into Singapore Dollars And Get 4% Yields With High Quality Baa3 Rated Bonds

      Headlines

      Fri, 17 May 2013

      By Randy Durig : We have long searched for a good fixed income investment opportunity in what is considered by some of financial industry's pundits to be one of the world's best currencies, the Singapore dollar. This week we target a medium term investment grade note denominated in Singapore ...

    2. LipoScience Gives Its Shareholders Chest Pains

      Headlines

      Tue, 14 May 2013

      By Stephen Simpson : There's a good reason that I always include the warning that small-cap med-techs carry above average risks, and LipoScience ( LPDX ) dutifully provided an example last week. Due in part to system placement delays and delays in ramping up new sales reps, this emerging ...

    3. New Morningstar Analyst Report for Becton , Dickinson and Company

      Stock Reports

      Thu, 9 May 2013

      health-care products will remain tepid. Becton is a defendant in several class-action ..... may incur substantial monetary damages. Becton 's diabetes sales may decline if large ..... internally manufactured delivery devices. Becton 's raw-material requirements include

    4. Bear Market Coming? Learn From The Last One

      Headlines

      Fri, 3 May 2013

      By John Kozey : Summary: A rising U.S. stock market that doesn't seem to want to pull back has made investors and forecasters nervous. Global economic indicators are softening -- especially in bellwether Germany -- and some pundits are saying there's a bear market looming. So what's a good way to

    5. Becton , Dickinson and Management Discusses Q2 2013 Results - Earnings Call Transcript

      Headlines

      Thu, 2 May 2013

      Becton , Dickinson and ( BDX ) Q2 2013 Earnings Call May 02, 2013 8:00 am ET Executives Monique ..... a href='http://seekingalpha.com/article/1394341- becton -dickinson-and-management-discusses-q2-2013-results-earnings-call-transcript

    6. BD Medical, a segment of Becton , Dickinson ([[ BDX ]] -0.3%) says its BD UltraSafe Plus Passive Needle Guard has received FDA 510(k) clearance as an anti-needlestick safety device. The device provides ...

      Headlines

      Fri, 12 Apr 2013

      BD Medical, a segment of Becton , Dickinson ( BDX -0.3% ) says its BD UltraSafe Plus Passive Needle Guard has received FDA 510(k) clearance as an anti-needlestick safety

    7. Several Big Growth Stories In Biotech: Keith Markey

      Headlines

      Thu, 28 Mar 2013

      By Life Sciences Report : As a former biotechnology researcher and 25-year Wall Street veteran, Griffin Securities Inc. Analyst and Scientific Director Keith Markey understands how novel, cutting-edge technology can produce extraordinary new products that bring in revenues with double-digit growth

    8. Becton , Dickinson and Company's CEO Hosts BD Simplist Product Line Launch Conference (Transcript)

      Headlines

      Thu, 28 Mar 2013

      Becton , Dickinson and Company ( BDX ) March 28, 2013 8:00 am ET Executives Monique Dolecki Vincent ..... a href='http://seekingalpha.com/article/1306911- becton -dickinson-and-company-special-call?source=feed

    9. Retirement Income: Portfolio Design For Maximum Current Income

      Headlines

      Tue, 26 Mar 2013

      By Doug Meeks : Portfolio design is fun. I love doing it and since I do it professionally I want it to work as often as possible. A portfolio design should be 99% done before any purchasing takes place. Trading stocks and working with the market can be quite emotional, so having a design in place

    10. If Quest Returns To Its Core Strengths, It Can Deliver Big Returns For Shareholders

      Headlines

      Thu, 21 Mar 2013

      By Paul Nouri : Long term investors are familiar with the chart below and the story that goes with it, but for those that are not familiar, I will go into a brief explanation. From the time Quest Diagnostics ( DGX ) went public in 1996 to 2006, investors were rewarded with a compound annual gain of

    « Prev12345Next »
    Content Partners